Profil Kompatibilitas Sediaan Intravena dan Kejadian Interaksi Obat Potensial pada Pasien Geriatri

Authors

  • Cici Resta Universitas BTH Tasikmalaya
  • Keni Idacahyati Universitas BTH Tasikmalaya
  • Muharam Priatna Universitas BTH Tasikmalaya

Abstract

Compatibility is a condition of the mixture between the drug ingredients and other medicinal substances or with solvents that affect the success of patient therapy. Geriatrics are elderly patients over 60 years in the treatment process usually get the drug more than 5 kinds of polypharmacy so that can potentially occur drug interactions. Objective: The aim of the study to determine the profile of intravenous preparations and potential interactions with the drug in geriatric patients. Methods: This study is an observational that is prospective with sampling techniques in Purposive Sampling. Results: Results of the research showed that the profile of compatibility of intravenous preparations in geriatrics patients is a mixture of NI or not information (54,90%) Compatible (32.4%), incompatibilities (11.3%) and not applicable or NA (1.4%). For the potential occurrence of drug interactions in geriatric patients in research has a severity of major 19%, moderate severity of 51%, and minor severity as much as 30%. The potential occurrence of inaccuracies based on the Beers Criteria 2019 analysis in geriatric patients is the use of drug proton pump inhibitor. Conclusion: The most common compactibility profile in geriatric patients is a mixture of not information and potential of drug interaction has a severity of moderat.

References

American Geriatrics Society 2019 Beers

Criteria Update Expert Panel, American

Geriatrics Society 2015 updated Beers

criteria for potentially inappropriate

medication use in older adults. J Am

Geriatr Soc. 63,11 (2015):2227– 2246.

Baxter, K., 2008, Stockley ’ s Drug

Interactions 8th ed. K. Baxter, ed.,

London: Pharmaceutical Press.

BPOM. 2015. Peraturan Kepala Badan

Pengawas Obat Dan Makanan

Republik Indonesia. Jakarta

BPOM. 2015. Pusat Informasi Obat Nasional

Badan Pengawasan Obat dan

Makanan.http://pionas.pom.go.id/ioni/b

ab-5infeksi/51-antibakteri/512-

sefalosporindanantibiotik-beta-laktam

Drugs.com, 2020, Prescription Drug

Information, Interactions & Side

Effects, Terdapat di:

https://www.drugs.com/drug_interactio

ns.html [Diakses pada Juli , 2020]

Dwijayanti, S., Irawati, S. and Setiawan, E.

(2016) ‘Profil Kompatibilitas Sediaan

Obat Intravena dengan Pelarut pada

Pasien Intensive Care Unit Profile of

Intravenous Admixture Compatibility in

the Intensive Care Unit ( ICU )

Patients’, 5(2).

Falter F,. 2012.Bedside Prosedures in the

ICU. Springer;

Feinstein J, Dai D, Zhong W, Freedman J,

Feudtner C.Potential drug-drug

interactions in infant, child, and

adolescent patients in children’s

hospitals. Pediatrics 2015;135:e99-

e108.

Horn, J. R., Hansten, P. D. dan Chan, L.

(2007) “Proposal for a New Tool to

Evaluate Drug Interaction Cases,” 41.

doi: 10.1345/aph.1H423.

Ilmawati Eldesi M.2015. Evaluasi Ketepatan

Penggunaan Antibiotik Pada Geriatri Di

RSUP Dr. Soeradji Tirtonegoro Klaten

Jawa Tengah Periode JanuariDesember 2014. Jawa Tengah

[SKRIPSI]

Kanji, S. dkk. (2010) ‘Systematic review of

physical and chemical compatibility of

commonly used medications

administered by continuous infusion in

intensive care units’, 38(9).

Kemenkes RI. (2014). Profil Kesehatan

Indonesia. Jakarta: Kementrian

Kesehatan Republik Indonesia.

Laksono, B. T. dkk. (2016) “Dampak anemia

pada fungsi kognitif pasien geriatri

yang dirawat di Rumah Sakit Umum

Pusat Sanglah Denpasar,”

(September), hal. 6–9.

Langerova P, Prokes M, Konvalinka M,

Furstova J, Urbanek K. Incidence of

potential drug interactions in

medication prescriptions for children

and adolescents in the University

Hospital Olomouc, Czech Republic.

Europe J Pediatric 2013;172:631-8

Medscape., 2020, Medscape Reference.

Aplikasi Medscape. (Diakses 2020)

Nasution. A.2015.Evaluasi penggunaan

antiemetik pada pasien rawat inap

geriatri di RSCM.Universitas Indonesia

[SKRIPSI]

Niu Q.,dkk., 2016, Combination Use of

Clopidogrel and Proton Pump Inhibitors

Increases Major Adverse

Cardiovascular Events in Patients With

Coronary Artery Disease: A MetaAnalysis, Jorunal of Cardiovaskuler

Pharmacology and Therapeutics, 22

(2), 142–152.

Purwaingsih A Dan Cahyo. 2018. Studi

Inkompatibilitas Parenteral Dan

Penggunaan Antibiotika Pada Pasien

Rawat Inap Di Rumah Sakit Surakarta

Universitas Setia Budi, Surakarta

Sodikin.2012.Prinsip Perawatan Demam

Pada Anak.Yogyakarta:Pustaka Pelajar

Trissel, Lawrence A. 2009. Handbook On

Injectable Drugs ed 15th. American

Society Of Health System Pharmacists.

Ussai S, Petelin R, Giordano A, Malinconico

M, Cirillo D, Pentimalli F. A pilot study

on the impact of known drug-drug

interactions in cancer patients. J

Experimental & Clinical Cancer

Research 2015;34:1-6.

Zou D. and Goh K.-L., 2017, East Asian

perspective on the interaction between

proton pump inhibitors and clopidogrel,

Jorunal Gastroenterology and

Hepatology, 32 (6), 1152–115

Downloads

Published

2022-01-25

Issue

Section

Articles